Mahoney Stephen F. 4
4 · Magenta Therapeutics, Inc. · Filed Feb 17, 2022
Insider Transaction Report
Form 4
Mahoney Stephen F.
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
[F1]2022-02-15+130,000→ 130,000 totalExercise: $3.19Exp: 2032-02-14→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on the first quarter following the vesting commencement date. The vesting commencement date is February 1, 2022.
Signature
/s/ Cindy Driscoll, Attorney-in-Fact for Stephen F. Mahoney|2022-02-17